Get started
STANDARD BIOTOOLSSTANDARD BIOTOOLSSTANDARD BIOTOOLS

STANDARD BIOTOOLS

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Forecast Bonds

FLB chart


Full chart

FLB upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪323.32 M‬ CHF
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.314 CHF
Net income (FY)
‪−126.14 M‬ CHF
Revenue (FY)
‪158.42 M‬ CHF
Shares float
‪365.93 M‬
Beta (1Y)
1.47

Employees


Employees (FY)
818
Change (1Y)
+279 +51.76%
Revenue / Employee (1Y)
‪193.67 K‬ CHF
Net income / Employee (1Y)
‪−154.20 K‬ CHF

About Standard BioTools Inc.


Sector
Health Technology
Industry
Medical Specialties
CEO
Michael Egholm
Website
standardbio.com
Headquarters
South San Francisco
Founded
1999
FIGI
BBG00LVDCKJ2
Standard BioTools Inc. engages in the provision of biotechnology tools and services for clinical research. It sells preparatory and analytical instruments for mass cytometry, polymerase chain reaction, library prep, single cell genomics, and consumables including integrated fluidic circuits (IFCs), assays, and reagents. The company was founded by Stephen D. Quake and Gajus Vincent Worthington on May 19, 1999 and is headquartered in South San Francisco, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

FLB news



Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

FLB highest yielding bonds


FLDM4094699
Standard BioTools Inc. 2.75% 01-FEB-2034
Yield to maturity
14.58%
Maturity date
Feb 1, 2034

See all FLB bonds 


Check out other big names from the same industry as FLB.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on BX exchange STANDARD BIOTOOLS stocks are traded under the ticker FLB.
FLB stock hasn't changed in a week, the last month showed zero change in price, over the last year there was no change in STANDARD BIOTOOLS price.
We've gathered analysts' opinions on STANDARD BIOTOOLS future price: according to them, FLB price has a max estimate of 2.10 CHF and a min estimate of 1.89 CHF. Watch FLB chart and read a more detailed STANDARD BIOTOOLS stock forecast: see what analysts think of STANDARD BIOTOOLS and suggest that you do with its stocks.
FLB stock is 0.00% volatile and has beta coefficient of 1.47. Track STANDARD BIOTOOLS stock price on the chart and check out the list of the most volatile stocks — is STANDARD BIOTOOLS there?
Today STANDARD BIOTOOLS has the market capitalization of ‪323.32 M‬, it has increased by 10.11% over the last week.
Yes, you can track STANDARD BIOTOOLS financials in yearly and quarterly reports right on TradingView.
STANDARD BIOTOOLS is going to release the next earnings report on Aug 6, 2025. Keep track of upcoming events with our Earnings Calendar.
FLB earnings for the last quarter are −0.06 CHF per share, whereas the estimation was −0.05 CHF resulting in a −27.27% surprise. The estimated earnings for the next quarter are −0.05 CHF per share. See more details about STANDARD BIOTOOLS earnings.
STANDARD BIOTOOLS revenue for the last quarter amounts to ‪36.11 M‬ CHF, despite the estimated figure of ‪35.50 M‬ CHF. In the next quarter, revenue is expected to reach ‪32.29 M‬ CHF.
FLB net income for the last quarter is ‪−23.05 M‬ CHF, while the quarter before that showed ‪−30.94 M‬ CHF of net income which accounts for 25.53% change. Track more STANDARD BIOTOOLS financial stats to get the full picture.
No, FLB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 14, 2025, the company has 818 employees. See our rating of the largest employees — is STANDARD BIOTOOLS on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. STANDARD BIOTOOLS EBITDA is ‪−97.81 M‬ CHF, and current EBITDA margin is −67.59%. See more stats in STANDARD BIOTOOLS financial statements.
Like other stocks, FLB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade STANDARD BIOTOOLS stock right from TradingView charts — choose your broker and connect to your account.